Kwality Pharmaceuticals Limited (BOM:539997)

India · Delayed Price · Currency is INR

3,293.90

-49.05 (-1.47%)

At close: Sep 4, 2026

Kwality Pharmaceuticals Earnings Call Transcripts

Fiscal Year 2027

Q1 26/27
Revenue guidance for FY 2027 is raised to over INR 700 crore with EBITDA margins of 26%-27%, driven by new product registrations and expansion in LATAM and MENA regions. Major CapEx is planned for hormone, oncology, and biosimilar programs, with strong growth expected through FY 2030.

Read full transcript →

Quarterly report
Slides